Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

144results about How to "Minor side effects" patented technology

Stannous oral care compositions

Disclosed are oral compositions comprising a stannous ion source, a polyvalent cation source and a mineral surface active agent, said compositions providing enhanced therapeutic efficacy derived from stannous fluoride and / or other stannous salt, including antimicrobial effects, control of breath malodor, control of dental plaque growth and metabolism, reduced gingivitis, decreased progression to periodontal disease, reductions in dentinal hypersensitivity and reduced coronal and root dental caries. The aforementioned benefits are provided along with significant improvements compared to conventional stannous containing compositions, including: 1) reduced levels of dental staining; 2) reduced astringency thereby improving aesthetic characteristics of the compositions; 3) reduction in dental calculus formation, and 4) enhanced stability, bioavailability and thus, efficacy of stannous. The mineral surface active agents are agents that are substantive to mineral surfaces such as teeth and have chelating activity for polyvalent cations including stannous (Sn+2), zinc (Zn+2), copper (Cu+2), aluminum (Al+2), iron (Fe+2, Fe+3), strontium (Sr+2), calcium (Ca+2), barium (Ba+2), magnesium (Mg+2), and manganese (Mn+2). Preferred mineral surface-active agents include polymers or copolymers containing phosphate, phosphonate, or carboxy groups. The compositions may also comprise a fluoride ion source and may be formulated as single phase or dual phase compositions.
Owner:THE PROCTER & GAMBNE CO

Aspirin-triggered lipid mediators

Aspirin triggered lipid mediators (ATLMs) are disclosed which are useful for the treatment of prevention of inflammation associated with various diseases, including ischemia.
Owner:THE BRIGHAM & WOMENS HOSPITAL INC

System and method for controlling the development of a software application

Certain example embodiments relate to techniques for controlling the development of a software application. The system includes an event channel for receiving at least one event that indicates an action performed by one of a plurality of existing development tools used in the development of the software application, a policy-based event engine for evaluating the at least one event and for initiating at least one action of one of the plurality of existing development tools in accordance with at least one policy, and a repository, for storing at least one artifact to define an architecture of the software application. The at least one artifact corresponds to a component of the software application and / or to a dependency between a first component and a second component of the software application.
Owner:SOFTWARE AG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products